卖什么
Mobile-health (SaMD) apps and digital therapeutics for health and medical care, such as pollen allergy and dry-eye apps and VR amblyopia training.
商业模式拆解
买家：谁掌握预算？
未核实Individual users (consumer), ophthalmology clinics, and HR/health-management departments at employers.
触发点：什么让他们现在购买？
未核实Eye discomfort without easy access to an ophthalmologist, and employer health-management (kenko keiei) needs.
工作流：什么输入变成什么输出？
Collects patient lifestyle data via mobile apps for disease risk visualization, self-management and behavior change, aiming at personalized and preventive medicine.
经济账：省了什么，怎么收费？
未核实Likely consultation/prescription revenue from online clinic platform plus B2B employee-benefit fees and health-management reports; no figures published.
渠道：怎么接触到客户？
Media and self-check apps funnel to online ophthalmology consultations; B2B corporate welfare service; supports telemedicine clinics.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-07-16 | C 轮 | — | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-13.